PPD boosts clinical trials testing with NeoGenomics lab opening in Singapore

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/KCHL)
(Image: Getty/KCHL)

Related tags Ppd NeoGenomics CRO Oncology Biomarker Pathology

To further support Asia-Pacific oncology trials, NeoGenomics opens new Singapore-based pharma services laboratory in the same building as PPD Laboratories’ central lab.

The contract research organization (CRO) PPD and NeoGenomics, which specializes in cancer genetics testing and information services, have opened the doors at a new oncology-focused clinical trials testing lab.

The expansion stems from a strategic alliance established in 2018 and, in the same building as the PPD Laboratories central lab, will help advance the companies’ initiative to provide a global solution for drug development programs in the region. It also boosts PPD’s specialized oncology and pathology biomarker testing offerings, according to the CRO.

“As today’s global clinical trials become more complex and there is an increased demand for pathology services in the Asia‐Pacific region, PPD Laboratories’ central lab has been building its pathology and molecular service offerings to support our clients’ clinical trials with an integrated solution,​said Christopher Fikry, MD, executive vice president, PPD Laboratories.

As part of the alliance, NeoGenomics has been providing a range of lab testing services to support PPD Laboratories’ oncology clinical trial activities in North America, Europe, and Asia-Pacific

“NeoGenomics’ extensive experience with oncology trials and cancer-focused genetic testing supplements PPD's internal anatomic pathology capabilities and strengthens its offering for clinical trials, particularly oncology trials,”​ Fikry told us.

Related news

Show more

Related products

show more

Are You Prepared to Meet the New FDA Guidelines?

Are You Prepared to Meet the New FDA Guidelines?

Elligo Health Research® | 23-Mar-2023 | Insight Guide

On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants...

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

How Sponsors Reduce Chaos in Decentralized Trials

How Sponsors Reduce Chaos in Decentralized Trials

Florence Healthcare | 08-Mar-2023 | Insight Guide

89% of research sponsors currently use and expect to continue the use of decentralized technologies and methods, according to our state of the industry...

Related suppliers

Follow us

Products

View more

Webinars